menu
    • menu

    Company profile for InnoCare Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical stage biopharmaceutical company committed to discovering, developing and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. Led by a world-class management team of seasoned industry executives, we have built a fully integrated biopharmaceutical platform with strong in-house R&D capabilities. Our vision is to become a global biopharmaceutical leader t...
    We are a clinical stage biopharmaceutical company committed to discovering, developing and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. Led by a world-class management team of seasoned industry executives, we have built a fully integrated biopharmaceutical platform with strong in-house R&D capabilities. Our vision is to become a global biopharmaceutical leader that develops anddelivers innovative therapies for patients worldwide. We have built a fully integrated platform that covers the entire spectrum of drug discovery and development functionalities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InnoCare PharmaChina Flag
    Country
    Country
    China
    Address
    Address
    Building 8, No. 8 Life Science Park Road, Zhongguancun Life Science Park, Chan...
    Telephone
    Telephone
    +86 10 66609999
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.innocarepharma.com/index.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innocare Approves Next-Gen TRK Inhibitor Zurletrectinib In China
    Innocare Approves Next-Gen TRK Inhibitor Zurletrectinib In China

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203741/0/en/InnoCare-Announces-Approval-of-the-Next-Generation-TRK-Inhibitor-Zurletrectinib-in-China.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    InnoCare Announces 1st Patient Dosed in Ph 2 Trial of Soficitinib
    InnoCare Announces 1st Patient Dosed in Ph 2 Trial of Soficitinib

    27 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/28/3195971/0/en/InnoCare-Announces-First-Patient-Dosed-in-the-Global-Phase-II-Clinical-Trial-of-TYK2-Inhibitor-Soficitinib-for-Treatment-of-Prurigo-Nodularis.html

    GLOBENEWSWIRE
    27 Nov 2025
    Share Share
    Innocare Initiates Clinical Trial For ADC ICP-B794 In China
    Innocare Initiates Clinical Trial For ADC ICP-B794 In China

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/31/3178053/0/en/InnoCare-Announces-First-Patient-Dosed-in-Clinical-Trial-of-Novel-ADC-ICP-B794-in-China.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Zenas Gains MS Hopeful in $2 B Deal with China's InnoCare
    Zenas Gains MS Hopeful in $2 B Deal with China's InnoCare

    09 Oct 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/zenas-makes-big-bet-ms-drug-striking-2b-licensing-deal-innocare

    FIERCE PHARMA
    09 Oct 2025
    Share Share
    InnoCare's HIBRUKA Approved for Zone Lymphoma in Singapore
    InnoCare's HIBRUKA Approved for Zone Lymphoma in Singapore

    07 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/08/3145779/0/en/InnoCare-Announces-Approval-of-HIBRUKA-Orelabrutinib-for-the-Treatment-of-Marginal-Zone-Lymphoma-in-Singapore.html

    GLOBENEWSWIRE
    07 Sep 2025
    Share Share
    InnoCare Starts BCL2 Inhibitor Mesutoclax Trial for BTKi MCL
    InnoCare Starts BCL2 Inhibitor Mesutoclax Trial for BTKi MCL

    21 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/21/3137226/0/en/InnoCare-Announces-First-Patient-Dosed-in-the-Registrational-Trial-of-BCL2-Inhibitor-Mesutoclax-for-Treatment-of-BTKi-treated-MCL-Patients-in-China.html

    GLOBENEWSWIRE
    21 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search